Biogen Idec To Collaborate With Isis On Treatment For Degenerative Muscle Disorder

The two companies build on an existing partnership in spinal muscular atrophy to address another muscle-wasting disease. For the second time, they’ve arranged an option deal, with milestones built in both before and after licensing.